Development – EUFEMED – is a not-for-profit association founded in 2015, formalising what had been an ongoing collaboration between several European societies working in human pharmacology. Established under the Belgian law, our initiative reflected the growing importance of early clinical drug development EUFEMED strives to be a ‘voice’ in the interest of exploratory medicines development in Europe. You can find our Mission Statement here.
EUFEMED promotes the interest of early clinical medicines development in professional organisations, international organisations, and public authorities.
Our aims are to help the members in all professional fields, organise meetings and conferences, training courses and specialist training, and much more… We develop standards and promote guidance documents in early medicines development to improve European competitiveness.
Read more about us here >
EUFEMED has been recognized as a stakeholder by European Medicines Agency (EMA) and is consulted for the revision of important European regulations and guidelines related to clinical drug development.
Location: London
Date: November 1, 12:00 AM - 2, 3:40 AM, 2025
The 2017 conference took place….…from the 18th to 19th May 2017 at the Kensington Conference and Events Centre in London and was preceded by a pre-conference workshop on the 17th May
Read More
Location: Lamot conference centre - Mechelen, Belgium
Date: Wednesday, May 21, 2025, Thursday, May 22, 2025, Friday, May 23, 2025
The conference will delve into the evolving landscape of early-phase clinical trials, featuring discussions on the role of genetic medicines, challenges in innovative therapy development, and the integration of artificial intelligence in clinical research.
Read More and RegisterEUFEMED represents national and European federations, organisations or associations active in early clinical medicines development. You can find our Mission Statement here.
Based on the successful collaborations since 2007 between our members, their comparable objectives and the growing importance of early clinical drug development EUFEMED strives to be a ‘voice’ in the interest of exploratory medicines development in Europe.
EUFEMED promotes the interest of early clinical medicines development in professional organisations, international organisations and public authorities.
Our aims are to help the members in all professional fields, organise meetings and conferences, courses and specialist training, and much more… We develop standards and promote guidance documents in early medicines development in order to improve European competitiveness.
Read more about us here >
EUFEMED
Quick Links
About
